Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
February 2008, Vol 1, No 1
Practice Management
Creating a 21st-Century Intelligent Health System
Newt Gingrich, PhD
,
Nancy Desmond, MEd, EdS
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
Perspectives
What Kind of Healthcare Debate Do We Want?
Robert E. Henry
Read More
Perspectives
Welcome to our community
Thomas McCarter, MD, FACP
Read More
Practice Management
Medicare Coverage Strategies: Impact of the MMA and PBMs
Stakeholder Perspective
by
Joseph R. Antos, PhD
Read More
Practice Management
Disruptive Innovation: Value-Based Health Plans
F. Randy Vogenberg, PhD, FASHP
Stakeholder Perspective
Value-Based Drug Benefit: Implications for Manufacturers
by
Kip Piper, MA, FACHE
Read More
Practice Management
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate
Al B. Benson III, MD, FACP, FASCO
,
Elizabeth Brown, MD
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
Original Research
Measuring the Value of Treatment to Patients: Patient-Reported Outcomes in Drug Development
Richard J. Willke, PhD
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
FDA Approvals
Approvable Letters in 2007 and the Outlook for 2008
Mark Senak, JD
Read More
Practice Management
The 2007 Pharmaceutical and Biotech Pipeline Year-End Summary: What it Says About the State of the Art of Discovery & Development
Michael F. Murphy, MD, PhD
Read More
Results 1 - 9 of 9